The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT

Last updated: May 19, 2010
Sponsor: Korea University
Overall Status: Trial Status Unknown

Phase

4

Condition

Dysrhythmia

Chest Pain

Atrial Fibrillation

Treatment

N/A

Clinical Study ID

NCT00959205
2009_KU_CARTO
  • Ages 20-85
  • All Genders

Study Summary

The purpose of this study is to evaluate the efficacy and safety of electroanatomic imaging compared to conventional method in patients with VT.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with AF or substrate-dependent VT

Exclusion

Exclusion Criteria:

  • administering with anticoagulants

Study Design

Total Participants: 160
Study Start date:
July 01, 2009
Estimated Completion Date:
February 28, 2011

Study Description

To evaluate the efficacy and safety of electroanatomic imaging (CARTO) compared to conventional fluoroscopically guided activation mapping (Conventional) method in patients with Atrial Fibrillation and Substrate-dependent Ventricular Tachycardia To evaluate cost-effectiveness of CARTO 3D image system compared to conventional method in the same study subjects

Connect with a study center

  • Asan Medical Center

    Seoul,
    Korea, Republic of

    Site Not Available

  • Korea medical center

    Seoul, 136-705
    Korea, Republic of

    Site Not Available

  • Seoul National University Hospital/Internal Medicine

    Seoul,
    Korea, Republic of

    Site Not Available

  • Seoul St. Mary's Hospital

    Seoul,
    Korea, Republic of

    Site Not Available

  • Severance Hospital

    Seoul,
    Korea, Republic of

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.